Clinical Trial Update: Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating NGX-4010 for painful HIV-associated neuropathy and postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Hiv-associated Neuropathy
• Postherpetic Neuralgia

Drugs mentioned

• NGX-4010 (capsaicin patch 8%)

Snippet

Sponsor: NeurogesX | Conditions: Herpes Zoster, Neuralgia | Phase 2 | Status: COMPLETED